From Poison Exposure to Recovery: How Alexipharmic Drugs Support Emergency Care
According to a new report by Polaris Market Research, the global Alexipharmic Drugs market was valued at USD 3.70 billion in 2024 and is projected to reach USD 6.25 billion by 2034, expanding at a CAGR of 5.40% over the forecast period. Growth is underpinned by rising poisoning incidence and emergency toxicology preparedness, expanding antidote availability in hospital and...
0 Reacties 0 aandelen 207 Views 0 voorbeeld